HEADER HORMONE 14-MAR-20 6M6F TITLE SOLUTION STRUCTURE OF DISULFIDE BOND MUTAION OF THE CORE DOMAIN OF TITLE 2 FIBROBLAST GROWTH FACTOR 21 (FGF21) COMPND MOL_ID: 1; COMPND 2 MOLECULE: FIBROBLAST GROWTH FACTOR 21; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: FGF-21; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FGF21; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI K-12; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 83333; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: K-12 KEYWDS DISULFIDE BOND MUTAION, BETA-TREFOIL CONFORMATION, BETA-KLOTHO KEYWDS 2 BINDING, METABOLIC REGULATOR, HORMONE EXPDTA SOLUTION NMR NUMMDL 10 AUTHOR L.ZHU,H.ZHAO,J.WANG REVDAT 3 14-JUN-23 6M6F 1 REMARK REVDAT 2 03-MAR-21 6M6F 1 JRNL REVDAT 1 20-JAN-21 6M6F 0 JRNL AUTH L.ZHU,H.ZHAO,J.LIU,H.CAI,B.WU,Z.LIU,S.ZHOU,Q.LIU,X.LI,B.BAO, JRNL AUTH 2 J.LIU,H.DAI,J.WANG JRNL TITL DYNAMIC FOLDING MODULATION GENERATES FGF21 VARIANT AGAINST JRNL TITL 2 DIABETES. JRNL REF EMBO REP. V. 22 51352 2021 JRNL REFN ESSN 1469-3178 JRNL PMID 33295692 JRNL DOI 10.15252/EMBR.202051352 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR NIH REMARK 3 AUTHORS : SCHWIETERS, KUSZEWSKI, TJANDRA AND CLORE REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6M6F COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 18-MAR-20. REMARK 100 THE DEPOSITION ID IS D_1300016174. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 7.0 REMARK 210 IONIC STRENGTH : 160 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 0.5 MM [U-99% 15N] FGF21SS, 20 REMARK 210 MM SODIUM PHOSPHATE, 100 MM REMARK 210 SODIUM CHLORIDE, 0.2 % W/V REMARK 210 SODIUM AZIDE, 90% H2O/10% D2O; REMARK 210 0.5 MM [U-99% 13C; U-99% 15N] REMARK 210 FGF21SS, 20 MM SODIUM PHOSPHATE, REMARK 210 100 MM SODIUM CHLORIDE, 0.2 % W/ REMARK 210 V SODIUM AZIDE, 90% H2O/10% D2O; REMARK 210 0.5 MM [U-99% 13C; U-99% 15N] REMARK 210 FGF21SS, 20 MM SODIUM PHOSPHATE, REMARK 210 100 MM SODIUM CHLORIDE, 0.2 % W/ REMARK 210 V SODIUM AZIDE, 100% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 3D CBCA(CO)NH; REMARK 210 3D HNCO; 3D HNCA; 3D HNCACB; 3D REMARK 210 HBHA(CO)NH; 3D HN(CO)CA; 3D REMARK 210 HN(CA)CO; 3D 1H-13C NOESY; 3D 1H- REMARK 210 15N NOESY; 3D HCCH-TOCSY; 3D REMARK 210 HCCH-COSY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ; 850 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE III REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : TOPSPIN, NMRPIPE, CCPNMR REMARK 210 ANALYSIS, X-PLOR NIH REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O ASP A 89 H CYS A 93 1.58 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 SER A 29 -164.28 -168.51 REMARK 500 1 GLN A 47 92.22 39.80 REMARK 500 1 ALA A 92 -34.77 -136.61 REMARK 500 1 LYS A 122 98.90 44.70 REMARK 500 1 SER A 123 -59.63 -179.61 REMARK 500 1 ALA A 129 110.66 64.03 REMARK 500 2 HIS A 26 7.98 -66.65 REMARK 500 2 LEU A 28 -89.58 -142.07 REMARK 500 2 GLN A 47 97.67 42.05 REMARK 500 2 LEU A 58 -71.47 -73.26 REMARK 500 2 ALA A 92 -31.04 -131.53 REMARK 500 2 LYS A 122 92.80 49.11 REMARK 500 2 SER A 123 72.17 33.59 REMARK 500 2 ARG A 126 88.83 38.10 REMARK 500 2 ASP A 127 93.89 -29.06 REMARK 500 3 HIS A 26 49.56 72.80 REMARK 500 3 SER A 30 135.23 -39.09 REMARK 500 3 GLN A 47 92.43 42.15 REMARK 500 3 LEU A 58 -70.60 -74.48 REMARK 500 3 ALA A 92 -32.61 -138.12 REMARK 500 3 LYS A 122 -168.14 41.94 REMARK 500 3 ASP A 127 163.09 -43.44 REMARK 500 3 ALA A 129 -39.98 175.04 REMARK 500 4 GLN A 14 53.56 -100.16 REMARK 500 4 LEU A 28 -69.77 60.77 REMARK 500 4 GLN A 47 98.95 43.47 REMARK 500 4 PRO A 60 109.92 -43.17 REMARK 500 4 ALA A 92 -32.34 -140.14 REMARK 500 4 ASN A 121 -166.85 41.33 REMARK 500 4 LYS A 122 -22.93 68.43 REMARK 500 5 HIS A 26 -68.75 -162.30 REMARK 500 5 LEU A 28 -61.52 70.69 REMARK 500 5 GLN A 47 91.49 37.47 REMARK 500 5 ASP A 127 172.71 -52.85 REMARK 500 5 ARG A 131 87.00 68.75 REMARK 500 6 LEU A 28 -71.45 66.08 REMARK 500 6 GLN A 47 99.69 46.70 REMARK 500 6 ARG A 131 109.89 -58.40 REMARK 500 7 LEU A 28 -143.29 -145.67 REMARK 500 7 GLN A 47 97.39 46.66 REMARK 500 7 LEU A 58 -73.10 -72.71 REMARK 500 7 ASN A 121 -36.83 68.04 REMARK 500 7 ARG A 126 -76.85 -155.72 REMARK 500 7 ALA A 129 146.53 -171.47 REMARK 500 7 ARG A 131 82.13 39.60 REMARK 500 8 GLN A 14 -69.75 59.47 REMARK 500 8 LEU A 28 -107.83 -80.00 REMARK 500 8 GLN A 47 90.05 46.26 REMARK 500 8 ASN A 121 -119.21 40.51 REMARK 500 8 SER A 123 -63.24 164.32 REMARK 500 REMARK 500 THIS ENTRY HAS 63 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6M6E RELATED DB: PDB REMARK 900 RELATED ID: 36324 RELATED DB: BMRB REMARK 900 SOLUTION STRUCTURE OF DISULFIDE BOND MUTAION OF THE CORE DOMAIN OF REMARK 900 FIBROBLAST GROWTH FACTOR 21 (FGF21) DBREF 6M6F A 13 136 UNP Q9NSA1 FGF21_HUMAN 42 164 SEQADV 6M6F SER A 23 UNP Q9NSA1 ASP 52 ENGINEERED MUTATION SEQADV 6M6F GLY A 24 UNP Q9NSA1 ASP 53 ENGINEERED MUTATION SEQADV 6M6F PRO A 25 UNP Q9NSA1 ALA 54 ENGINEERED MUTATION SEQADV 6M6F HIS A 26 UNP Q9NSA1 GLN 55 ENGINEERED MUTATION SEQADV 6M6F GLY A 27 UNP Q9NSA1 INSERTION SEQADV 6M6F LEU A 28 UNP Q9NSA1 GLN 56 ENGINEERED MUTATION SEQADV 6M6F SER A 29 UNP Q9NSA1 THR 57 ENGINEERED MUTATION SEQADV 6M6F SER A 30 UNP Q9NSA1 GLU 58 ENGINEERED MUTATION SEQADV 6M6F CYS A 31 UNP Q9NSA1 ALA 59 ENGINEERED MUTATION SEQADV 6M6F CYS A 43 UNP Q9NSA1 GLY 71 ENGINEERED MUTATION SEQADV 6M6F LEU A 137 UNP Q9NSA1 EXPRESSION TAG SEQADV 6M6F PRO A 138 UNP Q9NSA1 EXPRESSION TAG SEQADV 6M6F LEU A 139 UNP Q9NSA1 EXPRESSION TAG SEQADV 6M6F PRO A 140 UNP Q9NSA1 EXPRESSION TAG SEQADV 6M6F GLY A 141 UNP Q9NSA1 EXPRESSION TAG SEQRES 1 A 129 GLY GLN VAL ARG GLN ARG TYR LEU TYR THR SER GLY PRO SEQRES 2 A 129 HIS GLY LEU SER SER CYS HIS LEU GLU ILE ARG GLU ASP SEQRES 3 A 129 GLY THR VAL GLY CYS ALA ALA ASP GLN SER PRO GLU SER SEQRES 4 A 129 LEU LEU GLN LEU LYS ALA LEU LYS PRO GLY VAL ILE GLN SEQRES 5 A 129 ILE LEU GLY VAL LYS THR SER ARG PHE LEU CYS GLN ARG SEQRES 6 A 129 PRO ASP GLY ALA LEU TYR GLY SER LEU HIS PHE ASP PRO SEQRES 7 A 129 GLU ALA CYS SER PHE ARG GLU LEU LEU LEU GLU ASP GLY SEQRES 8 A 129 TYR ASN VAL TYR GLN SER GLU ALA HIS GLY LEU PRO LEU SEQRES 9 A 129 HIS LEU PRO GLY ASN LYS SER PRO HIS ARG ASP PRO ALA SEQRES 10 A 129 PRO ARG GLY PRO ALA ARG PHE LEU PRO LEU PRO GLY HELIX 1 AA1 SER A 48 GLU A 50 5 3 HELIX 2 AA2 ASP A 89 SER A 94 1 6 SHEET 1 AA1 6 ASN A 105 SER A 109 0 SHEET 2 AA1 6 PHE A 95 LEU A 99 -1 N ARG A 96 O GLN A 108 SHEET 3 AA1 6 VAL A 62 GLY A 67 -1 N ILE A 63 O PHE A 95 SHEET 4 AA1 6 LEU A 52 LYS A 59 -1 N LYS A 56 O GLN A 64 SHEET 5 AA1 6 VAL A 15 TYR A 21 -1 N ARG A 16 O LEU A 55 SHEET 6 AA1 6 LEU A 137 PRO A 140 -1 O LEU A 137 N TYR A 21 SHEET 1 AA2 2 HIS A 32 ILE A 35 0 SHEET 2 AA2 2 VAL A 41 ALA A 44 -1 O GLY A 42 N GLU A 34 SHEET 1 AA3 2 PHE A 73 GLN A 76 0 SHEET 2 AA3 2 LEU A 82 SER A 85 -1 O SER A 85 N PHE A 73 SSBOND 1 CYS A 31 CYS A 43 1555 1555 2.03 SSBOND 2 CYS A 75 CYS A 93 1555 1555 2.02 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1